Maximo F. Nougues, CFO of Puma Biotechnology Inc. ($PBYI), sold shares on the open market four times in the last year, totaling nearly $98,000. His most recent sale occurred on January 7, 2026. These sales rank him 9,624th among 11,678 insiders by value sold, well below the average of $8.6 million across 6.4 transactions per insider. Nougues made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Stock Option (Right to Buy) | 66541 | $0.00 | 66,541.0000 | 50,929,893 | 9999.99% | 0.13% |
| Feb. 18, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Common Stock | 46739 | $0.00 | 240,023.0000 | 50,929,893 | 24.18% | 0.09% |
| Jan. 7, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 6405 | $5.88 | 193,284.0000 | 50,929,893 | 3.21% | 0.01% |
| Jan. 6, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 4540 | $5.84 | 199,689.0000 | 50,929,893 | 2.22% | 0.01% |
| July 8, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 5587 | $3.53 | 208,164.0000 | 49,100,433 | 2.61% | 0.01% |
| July 9, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 3935 | $3.54 | 204,229.0000 | 49,100,433 | 1.89% | 0.01% |
| Feb. 7, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Common Stock | 61456 | $0.00 | 213,751.0000 | 49,100,433 | 40.35% | 0.13% |
| Feb. 7, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Stock Option (Right to Buy) | 85067 | $0.00 | 85,067.0000 | 49,100,433 | 9999.99% | 0.17% |
| Jan. 2, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 10227 | $3.15 | 152,295.0000 | 49,100,433 | 6.29% | 0.02% |
| July 17, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 4156 | $3.70 | 162,522.0000 | 47,550,852 | 2.49% | 0.01% |
| July 2, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 5295 | $3.27 | 166,678.0000 | 47,550,852 | 3.08% | 0.01% |
| Feb. 12, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Common Stock | 43307 | $0.00 | 171,973.0000 | 47,550,852 | 33.66% | 0.09% |
| Feb. 12, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Stock Option (Right to Buy) | 59946 | $0.00 | 59,946.0000 | 47,550,852 | 9999.99% | 0.13% |
| Jan. 3, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 15682 | $4.49 | 128,666.0000 | 47,550,852 | 10.86% | 0.03% |
| July 3, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 14680 | $3.31 | 144,348.0000 | 44,929,998 | 9.23% | 0.03% |
| Feb. 10, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Common Stock | 58601 | $0.00 | 159,028.0000 | 44,929,998 | 58.35% | 0.13% |
| Feb. 10, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | A | Stock Option (Right to Buy) | 81399 | $0.00 | 81,399.0000 | 44,929,998 | 9999.99% | 0.18% |
| Jan. 3, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | NOUGUES MAXIMO F | Chief Financial Officer | S | Common Stock | 10499 | $4.18 | 100,427.0000 | 44,929,998 | 9.46% | 0.02% |